Bristol-Myers Squibb is a global biopharmaceutical company founded in 1887. It discovers, develops, and delivers innovative medicines to transform patients' lives through science, with a focus on serious diseases. The company employs approximately 32,500 people worldwide and operates in more than 100 countries.
The company's research and development activities span several technical domains, including biopharmaceutical research, immunotherapy, cell therapy, and drug discovery and development. Its portfolio includes pioneering cardiovascular therapies and treatments that are revolutionizing cancer care through immunotherapy. Its industry verticals encompass oncology, hematology, immunology, cardiology, and fibrosis.
Bristol-Myers Squibb's structure combines the reach and resources of a major pharmaceutical company with the entrepreneurial spirit of a biotech firm. The company expresses a commitment to health equity and supporting vulnerable populations globally through the Bristol Myers Squibb Foundation.
